CIDRAP company blog

AstraZeneca vaccine doesn't prevent B1351 Covid in early trial

cidrap.umn.edu published 2021-03-16

Two doses of the AstraZeneca-Oxford University COVID-19 vaccine were ineffective against mild-to-moderate infections with the B1351 variant first identified in South Africa, according to a phase 1b-2 clinical trial published today in the New England Journal of Medicine .

Points

263

HN comments

208

Submissions

1

Cited by

0 commenters

Science & SpaceSociety, Policy & Culture2021

Related posts from the same era

Mechanical Watch

Bartosz Ciechanowski20224,298 points704 commentscited by 59 details

Sound

Bartosz Ciechanowski20223,053 points238 commentscited by 8 details

GPS

Bartosz Ciechanowski20222,900 points320 commentscited by 32 details

Gears

Bartosz Ciechanowski20202,760 points227 commentscited by 11 details

Internal Combustion Engine

Bartosz Ciechanowski20212,333 points498 commentscited by 16 details

Cameras and Lenses

Bartosz Ciechanowski20202,132 points269 commentscited by 10 details